Navigation Links
Kidney Cancer Drug Linked to Higher Rate of Heart Problems
Date:2/13/2008

A second study, also being presented at the conference, found that a procedure known as partial nephrectomy is being underutilized in treating patients with small kidney tumors.

Partial nephrectomy involves removing only the part of the kidney bearing the tumor, while radical nephrectomy involves removing the whole kidney.

"Radical nephrectomy has essentially been the gold standard since the 1940s and 1950s," said study author Dr. William Huang, an assistant professor of urologic oncology at New York University School of Medicine. "There is a greater than 90 percent cure rate, but the procedure does increase the risk of going on to develop chronic kidney disease."

Partial nephrectomy appears to be equally effective in tumors less than 4 centimeters and even in some up to 7 centimeters in size. Although there are potential complications here as well, partial nephrectomy does a better job of preserving kidney function and preventing chronic kidney disease.

Huang and his colleagues found that women, older patients and patients with cerebrovascular disease such as stroke were more likely to have the entire kidney removed. Only 20.5 percent of men and 22.4 percent of patients aged 66 to 69 had the partial procedure, versus 16 percent of women and 7.1 percent of patients aged 85 and over.

"Most of the newly diagnosed kidney tumors are amenable to partial nephrectomy but in those newly diagnosed, many continue to undergo radical nephrectomy," Huang said. "Partial nephrectomy is an option for most patients with newly diagnosed tumors and may be a better option, because people with kidney tumors may have other conditions."

More information

There's more on kidney cancer at the U.S. National Cancer Institute.



SOURCES: Patrick Lowry, M.D., assistant professor, surgery, Texas A&am
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. Expenses Overshadow Optimism for Kidney Failure Patients
3. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
4. Lowering Blood Protein Wont Help Kidney Patients
5. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
6. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
7. Metabolic syndrome heightens risk for development of uric-acid kidney stones
8. Nighttime Home Dialysis a Boon for Kidney Patients
9. New Survey Reveals Kidney Patients Concern About Medicare Policies
10. Nations Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care
11. Kidney Awareness Time (KAT) Walk Raised Awareness and $400,000 for Kidney Education and Prevention Programs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kidney Cancer Drug Linked to Higher Rate of Heart Problems 
Kidney Cancer Drug Linked to Higher Rate of Heart Problems
(Date:11/21/2008)...on January 8, 2009 , , TORONTO, Nov. 21 /PR... ("MedEmerg") (OTCBB: MDER), one of Canada,s leadi...hat it has obtained an interim order from the Onta...ously announced plan of arrangement (the "Arrangem...M") will acquire all of MedEmerg,s outstanding sha...
(Date:11/21/2008)...l/ -- The Providence Service,Corporation (Nasdaq:...e Company,s,Chief Operating Officer, has been app...Norris, appointment fills the vacancy left by the ...returns the board to six members. Mr.,Norris wil... Mr. Norris, age 41, has been with Providence sin...
(Date:11/21/2008)... The University of Texas M. D. Anderson Cancer C...rt to eradicate breast cancer in Panama through th...arch of the Americas today at an event with Laura ...ian Fernandez de Torrijos, the First Lady of Panam...tive are the U.S. Department of State and Susan G....
(Date:11/21/2008)...al membership of the Medical,Advertising Hall of ...r Annual,Awards Dinner to be held February 10, 20...hievement Award will also be given. , The 2... Fame are: , Ronald Pantello, who began his adv...r & Hennessey. In 1980 he left Sudler & He...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...utionary weapon for the war against the bulges and...tates. Alli- a fat blocker is the first FDA appro...ithout a prescription. The prescription diet drug ...store shelves with a new name and in nonprescripti...
...o Springs community of U.S is waiting with bated b...e if any person has contracted TB from a young nu...to health officials, tuberculosis has been found r...a Dangol, a young Nepalese student at Colorado Sp...
...that men spends more waking time thinking about...subject in equal measure once the lights are out. ...ecades, the canadian research team report that abo...am reports from both genders contain some form of ...
... at the La Jolla Institute for Allergy & Immunolog...entually lead to a new therapeutic approach for tr...as rheumatoid arthritis, colitis, psoriasis and ot...atory mice, demonstrated the role of retinoic acid...
Other Medicine News:Health News:Alli- a New Weapon for War Against the Bulges 2Health News:Fears Of Spread Of TB After Students Death 2Health News:Equality Among Genders in Terms of Sex Dreams 2Health News:New Therapeutic Approach for Autoimmune and Inflammatory Diseases 2
(Date:11/20/2008)...November 20 Arpida (SWX:...ugs Advisory Committee of the,U.S. Food and Drug ...,approval of intravenous iclaprim, an antibiotic ...ients with complicated skin and skin structure inf...cillin-resistant Staphylococcus,aureus (MRSA). ,...
(Date:11/20/2008)...0 Bionovo, Inc.,(Nasdaq...lts from the Phase 1B,clinical trial of their lea...ancer, BZL101, at the Society for Integrative Onco... Georgia. The Company,s oral presentation was sel...nted as a part of the Best of the,SIO Session on ...
(Date:11/20/2008)... Radius Health ("Radius") announced...n to its second institutional financing round, inc... and the total amount raised since the company,s i...onal investors participated in the financing, led ... Capital, The Wellcome Trust, HealthCare Ventures,...
(Date:11/20/2008)...e-FirstCall/ -- PAREXEL International Corporation ...cal services provider, today announced that it has...ory consulting and clinical research capabilities.... has locations throughout five important biopharma...ude Argentina, Brazil, Chile, and Mexico. This exp...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Emageon Receives Best in KLAS Cardiology PACS Award 15216 1Emageon Receives Best in KLAS Cardiology PACS Award 15216 2QMed Inc Reports Year End and Fourth Quarter Results 15213 1QMed Inc Reports Year End and Fourth Quarter Results 15213 2QMed Inc Reports Year End and Fourth Quarter Results 15213 3QMed Inc Reports Year End and Fourth Quarter Results 15213 4QMed Inc Reports Year End and Fourth Quarter Results 15213 5QMed Inc Reports Year End and Fourth Quarter Results 15213 6QMed Inc Reports Year End and Fourth Quarter Results 15213 7Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 1Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 2NCPA Statement on Californias Delay of E Pedigree Implementation 15207 1NCPA Statement on Californias Delay of E Pedigree Implementation 15207 2
...ase History Highlighted in AACR Cancer Journal , A...gen,Therapeutics, Inc. (NASDAQ:INGN) announced tod... clinical benefit of its lead product,Advexin in a...n as,Li-Fraumeni Syndrome (LFS), a genetic disorde...tumor suppressor gene. This is the,first reported ...
...SLO, Norway, 30 May 2007 - Algeta ASA (OSE: ALGETA...unces that Professor,Øyvind Bruland, of the...geta, will present a Poster and Discussion entitle...one refractory,prostate cancer (HRPC): Results fro...," at the American Society of,Clinical Oncology,s ...
Other Medicine Technology:Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2
3 mm, 130 degree upwards cutting, detachable.
Sabre 180 is a powerful niche generator.
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator.
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag.
Medicine Products: